FASEB president Dr. William T. Talman, testifies on behalf of increased funding for the National Science Foundation

William T. Talman, M.D., President of the Federation of American Societies for Experimental Biology (FASEB), testified today in support of increased funding for the National Science Foundation (NSF) before the House Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies. "The NSF budget has both immediate and long-term consequences for our economy, security, and quality of life," Talman stated. "Strong and sustained investment in NSF enables transformational research and training essential to the future success and competitiveness of the U.S."

FASEB's President gave examples of NSF projects that have had implications for the medical field, including scientific advances in imaging technologies, synthetic biology research to improve production of therapeutics, and robotics research to revolutionize surgical procedures. "NSF-funded research creates the foundation for new technologies and therapeutics," Talman testified. "Through a rigorous merit review, the best and most promising research is identified."

Talman also spoke to the Subcommittee about the critical role NSF plays in training and career development for scientists and engineers. "The agency is also committed to achieving excellence in science, technology, engineering, and math education at all levels," he said. "It is the only federal agency that promotes research and education across all fields of science and engineering, making it a crucial force for interdisciplinary synergies."

FASEB supports a FY 2012 appropriation of $7.8 billion for NSF. Dr. Talman's complete testimony may be found here.

Provided by Federation of American Societies for Experimental Biology